Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PhaseⅡ, Open Label, Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma

NCT01308645 is registered in ClinicalTrials.gov with SBPharmaceutical IND, Co., LTD as lead sponsor.

NCT NCT01308645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01308645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PhaseⅡ, Open Label, Clinical Trial to Investigate Safety and Efficacy of SB Injection in Patients With Advanced or Primary Hepatocellular Carcinoma
Lead sponsor
SBPharmaceutical IND, Co., LTD
Phase
Phase 2
Overall status
Unknown status
Start date
December 31, 2010
Completion date
March 31, 2012
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma